tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TARA Stock Latest News

Buy Rating on TARA-002 Backed by Best-in-Class NMIBC Data, FDA-Aligned Phase 3 Strategy, and Solid Cash Runway
RatingsBuy Rating on TARA-002 Backed by Best-in-Class NMIBC Data, FDA-Aligned Phase 3 Strategy, and Solid Cash Runway
3d ago
TARA
Protara Therapeutics: Buy Rating on Strong TARA-002 Phase 2 Data, Clear Late-Stage Pipeline Roadmap, and Cash Runway Through 2028
PremiumRatings
Protara Therapeutics: Buy Rating on Strong TARA-002 Phase 2 Data, Clear Late-Stage Pipeline Roadmap, and Cash Runway Through 2028
13d ago
TARA
Protara Therapeutics reports Q4 EPS (37c), consensus (31c)
PremiumThe Fly
Protara Therapeutics reports Q4 EPS (37c), consensus (31c)
13d ago
TARA
Protara Therapeutics sees cash runway into 2028
PremiumThe Fly
Protara Therapeutics sees cash runway into 2028
13d ago
TARA
TARA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
TARA Upcoming Earnings Report: What to Expect?
15d ago
TARA
De-Risked Lead Asset and Underappreciated Pipeline Upside Support Buy Rating on Protara
PremiumRatingsDe-Risked Lead Asset and Underappreciated Pipeline Upside Support Buy Rating on Protara
19d ago
TARA
Protara Therapeutics initiated with an Overweight at JPMorgan
Premium
The Fly
Protara Therapeutics initiated with an Overweight at JPMorgan
19d ago
TARA
Protara Highlights Strong Phase 2 Data for TARA-002
Premium
Company Announcements
Protara Highlights Strong Phase 2 Data for TARA-002
27d ago
8K
TARA
Reframing TARA‑002’s Potential: Underappreciated Durability and Commercial Upside in BCG‑Unresponsive NMIBC
PremiumRatings
Reframing TARA‑002’s Potential: Underappreciated Durability and Commercial Upside in BCG‑Unresponsive NMIBC
28d ago
TARA
Buy Rating on TARA-002 Supported by Comparable Efficacy and $500M Peak Sales Opportunity in Bladder Cancer
PremiumRatings
Buy Rating on TARA-002 Supported by Comparable Efficacy and $500M Peak Sales Opportunity in Bladder Cancer
28d ago
TARA
Protara Therapeutics says TARA-002 demonstrates 68% CR rate at 6 months
PremiumThe Fly
Protara Therapeutics says TARA-002 demonstrates 68% CR rate at 6 months
28d ago
TARA
Protara Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Protara Therapeutics management to meet with Oppenheimer
2M ago
TARA
Protara Therapeutics highlights recent updates, 2026 milestones
PremiumThe FlyProtara Therapeutics highlights recent updates, 2026 milestones
2M ago
TARA
3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
Premium
Market News
3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
3M ago
OLMA
ORIC
Protara doses first patient in Phase 3 trial of IV Choline Chloride
Premium
The Fly
Protara doses first patient in Phase 3 trial of IV Choline Chloride
3M ago
TARA
Protara Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Protara Therapeutics initiated with an Overweight at Piper Sandler
3M ago
TARA
Regulatory De-Risking and Expanding Indications Drive Attractive Risk–Reward for Protara Therapeutics’ TARA-002
PremiumRatings
Regulatory De-Risking and Expanding Indications Drive Attractive Risk–Reward for Protara Therapeutics’ TARA-002
3M ago
TARA
Protara gets FDA Breakthrough Therapy and Fast Track Designations for TARA-002
PremiumThe Fly
Protara gets FDA Breakthrough Therapy and Fast Track Designations for TARA-002
3M ago
TARA
Protara Therapeutics Raises $86.3 Million in Offering
PremiumCompany Announcements
Protara Therapeutics Raises $86.3 Million in Offering
3M ago
8K
TARA
Protara Therapeutics Completes $75 Million Stock Offering
PremiumCompany AnnouncementsProtara Therapeutics Completes $75 Million Stock Offering
3M ago
8K
TARA
Protara Therapeutics down 18% at $5.66 after equity offering
Premium
The Fly
Protara Therapeutics down 18% at $5.66 after equity offering
4M ago
TARA
Protara Therapeutics 13.04M share Spot Secondary priced at $5.75
Premium
The Fly
Protara Therapeutics 13.04M share Spot Secondary priced at $5.75
4M ago
TARA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >